Primary hyperoxaluria
Non-billable headerHCC V28 50
E72.53 is a non-billable header code. Use one of the more specific codes below.
Inclusion terms
Applicable to
- Oxalosis
- Oxaluria
Includes (from E72)
- Note: All neoplasms, whether functionally active or not, are classified in Chapter 2. Appropriate codes in this chapter (i.e. E05.8, E07.0, E16-E31, E34.-) may be used as additional codes to indicate either functional activity by neoplasms and ectopic endocrine tissue or hyperfunction and hypofunction of endocrine glands associated with neoplasms and other conditions classified elsewhere.
Excludes1
Not coded here — never report together with this code.
- secondary hyperoxaluria (E72.54-)
- transitory endocrine and metabolic disorders specific to newborn (P70-P74) (from E72)
- androgen insensitivity syndrome (E34.5-) (from E72)
- congenital adrenal hyperplasia (E25.0) (from E72)
- hemolytic anemias attributable to enzyme disorders (D55.-) (from E72)
- Marfan syndrome (Q87.4-) (from E72)
- 5-alpha-reductase deficiency (E29.1) (from E72)
- disorders of: (from E72)
- aromatic amino-acid metabolism (E70.-) (from E72)
- branched-chain amino-acid metabolism (E71.0-E71.2) (from E72)
- fatty-acid metabolism (E71.3) (from E72)
- purine and pyrimidine metabolism (E79.-) (from E72)
- gout (M1A.-, M10.-) (from E72)
Excludes2
Not included here — may be reported together when both conditions exist.
Also known as
- Oxalosis
- Oxaluria
- Disorder, glycine metabolism, oxalosis
- Disorder, glycine metabolism, oxaluria
- Hyperoxaluria, primary